The industry is facing an even bigger challenge to recruit, retain, and engage with patients due to COVID-19, which has delayed and de-prioritized many clinical trials across the globe. In response, IBM Watson Health has optimized IBM Clinical Development to enable decentralized trials for its clients.

Event Details

New Ways to Apply Decentralized Trials during COVID-19

Webinar

Live
Available On Demand until